Sangamo Therapeutics, Inc.

    Sangamo Therapeutics, Inc.

    XXETR:GBY
    - -
    EUR
    - -
    - -
    Sangamo Therapeutics, Inc.
    XETR:GBY
    (Deutsche Borse Xetra)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2008
    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    TTM
    USD
    0.4
    0.53
    0.46
    0.2
    0.41
    0.43
    0.68
    0.57
    0.27
    0.47
    0.87
    0.91
    0.88
    0.77
    - -
    - -
    - -
    Revenue per Share
    -0.6
    -0.44
    -0.55
    -0.71
    -0.42
    -0.48
    -0.39
    -0.58
    -1.02
    -0.7
    -0.7
    -0.85
    -0.9
    -1.23
    - -
    - -
    - -
    Basic EPS, GAAP
    -0.44
    -0.15
    -0.55
    -0.52
    -0.17
    -0.36
    -0.08
    -0.48
    -0.94
    0.1
    -0.07
    -1.47
    1.15
    -1.77
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    -4.25
    -4.57
    -4.81
    -5
    -5.21
    -5.39
    -4.89
    -5.28
    -6.24
    -6.33
    -5.79
    -5.85
    -5.78
    -6.6
    - -
    - -
    - -
    Book Value per Share
    1.36
    1.71
    1.24
    1.59
    1.23
    2.11
    3.03
    2.74
    1.91
    2.39
    2.82
    3.04
    2.95
    1.95
    - -
    - -
    - -
    Tangible Book Value per Share
    41
    42
    45
    51
    53
    56
    67
    70
    71
    78
    97
    112
    134
    145
    - -
    - -
    - -
    Basic Weighted Avg Shares
    16
    22
    21
    10
    22
    24
    46
    40
    19
    37
    84
    102
    118
    111
    111
    176
    12
    Sales/Revenue/Turnover
    -156.77
    -87.45
    -119.85
    -347.14
    -102.51
    -110.66
    -58.38
    -118.51
    -374.23
    -154.13
    -91.35
    -102.69
    -109.61
    -165.61
    -180.85
    -67.52
    -1,681.69
    Operating Margin (%)
    1
    1
    1
    1
    1
    1
    1
    1
    1
    1
    2
    10
    13
    18
    21
    22
    16
    Depreciation Expense
    -24
    -19
    -25
    -36
    -22
    -27
    -26
    -41
    -72
    -55
    -68
    -95
    -121
    -178
    -192
    -258
    -250
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -150.14
    -83.77
    -119.46
    -346.45
    -102.81
    -110.32
    -57.59
    -102.94
    -369.58
    -149.23
    -80.91
    -92.93
    -102.37
    -161.05
    -172.76
    -146.3
    -2,033.68
    Profit Margin (%)
    54
    70
    54
    78
    60
    87
    170
    192
    136
    204
    332
    336
    516
    271
    189
    47
    1
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    4
    25
    28
    41
    38
    44
    39
    34
    29
    LT Debt
    55
    72
    56
    80
    65
    122
    207
    192
    136
    188
    367
    433
    497
    375
    295
    83
    24
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    5
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    34
    31
    29
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    178
    204
    208
    Market Capitalization
    - -
    - -
    - -

    Working Capital

    USD

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    94
    69
    40
    Cash, Cash Equivalents & STI
    81
    54
    28
    Accounts Receivable, Net
    1
    1
    1
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    48
    40
    39
    Payables & Accruals
    34
    34
    33
    ST Debt
    5
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.2%
    -17.02%
    -71.9%
    Free Cash Flow
    219.18%
    394.08%
    0.9%
    Net Income, GAAP
    28.64%
    31.14%
    34.09%
    Sales/Revenue/Turnover
    33.41%
    17.84%
    58.34%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    28
    29
    26
    27
    111
    2023
    158
    7
    9
    2
    176
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    -0.3
    -0.29
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business